About The TSA

This author has not yet filled in any details.
So far The TSA has created 266 blog entries.

We need you

We want to make sure that each and every one of you, our valued supporters, are getting all that YOU want and need from the TSA. To help us to do this we share our latest information through our monthly TSA e-newsletter which you can choose to

Welsh Info Day 2019: Free tickets now on-sale!

Registration for the Welsh Info Day, taking place Saturday 28 September at University Hospital of Wales, Heath Park, Cardiff, is now open! Free tickets can be registered via Eventbrite here. The Welsh Info Day is an opportunity for the TSC community in Wales to attend

Votubia (Everolimus) Fact Sheet

Votubia® (everolimus) Fact Sheet What is Votubia® (everolimus)? Votubia® (everolimus), is a prescription-only medicine for patients at least three years of age with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC) who require therapeutic intervention but are not amenable to surgery. Votubia

Votubia Launched in UK

The Tuberous Sclerosis Association (TSA) is delighted that the drug Votubia® (Everolimus) was launched in the UK today, to provide a treatment option for people with Tuberous Sclerosis Complex (TSC) who have growing non-malignant brain tumours which are not suitable for removal by surgery. Everolimus, which